Q32 Bio Inc.
QTTB
$3.66
$0.257.33%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 58.01% | 44.11% | -1,172.01% | 47.58% | -25.40% |
| Total Depreciation and Amortization | -26.02% | -24.79% | -3.25% | -3.23% | -0.81% |
| Total Amortization of Deferred Charges | -8.00% | -25.76% | 65.52% | 63.33% | 614.29% |
| Total Other Non-Cash Items | 13.15% | 50.71% | 104.01% | -13.06% | -82.38% |
| Change in Net Operating Assets | 151.48% | 50.99% | -286.28% | -93.21% | -114.19% |
| Cash from Operations | 78.33% | 52.05% | 14.22% | -6.65% | -222.77% |
| Capital Expenditure | -- | -- | -- | -- | -5,700.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 994,300.00% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -- | -- | -- | 317.11% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -256.77% | -- | -- | 317.11% | 232.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 32.51% | 40.32% | -114.70% | -4.46% | -152.98% |